Cells often use multiple pathways to repair the same DNA lesion, and the choice of pathway has substantial implications for the fidelity of genome maintenance. DNA interstrand crosslinks covalently link the two strands of DNA, and thereby block replication and transcription; the cytotoxicity of these crosslinks is exploited for chemotherapy. In Xenopus egg extracts, the collision of replication forks with interstrand crosslinks initiates two distinct repair pathways. NEIL3 glycosylase can cleave the crosslink 1 ; however, if this fails, Fanconi anaemia proteins incise the phosphodiester backbone that surrounds the interstrand crosslink, generating a double-strand-break intermediate that is repaired by homologous recombination 2 . It is not known how the simpler NEIL3 pathway is prioritized over the Fanconi anaemia pathway, which can cause genomic rearrangements. Here we show that the E3 ubiquitin ligase TRAIP is required for both pathways. When two replisomes converge at an interstrand crosslink, TRAIP ubiquitylates the replicative DNA helicase CMG (the complex of CDC45, MCM2-7 and GINS). Short ubiquitin chains recruit NEIL3 through direct binding, whereas longer chains are required for the unloading of CMG by the p97 ATPase, which enables the Fanconi anaemia pathway. Thus, TRAIP controls the choice between the two known pathways of replication-coupled interstrand-crosslink repair. These results, together with our other recent findings 3,4 establish TRAIP as a master regulator of CMG unloading and the response of the replisome to obstacles.
A critical gap in our knowledge concerns the identity of the E3 ubiquitin ligase that ubiquitylates CMG at ICLs to activate CMG unloading and entry into the Fanconi anaemia pathway. The RING E3 ligase TRAIP (TRAF-interacting protein) is essential for cell proliferation 15 , and hypomorphic TRAIP mutations cause microcephalic primordial dwarfism 16 . Because TRAIP associates with ICL-containing chromatin 17 and its knockdown sensitizes cells to mitomycin C 18 , we asked whether TRAIP promotes CMG unloading at ICLs. We used Xenopus egg extracts to replicate a plasmid containing a site-specific cisplatin-ICL (pICL Pt ) (Extended Data Fig. 1a ). In mock-depleted extract, forks converged on the ICL and stalled, generating a discrete 'slow-figure-8' intermediate that was converted to a 'fast-figure-8' species upon CMG unloading 9 (Fig. 1b , lanes 1-3, Extended Data Fig. 1b ; for gel source data, see Supplementary Fig. 1) . Notably, the depletion of TRAIP (Extended Data Fig. 2a ) caused an accumulation of the slow-figure-8 species (Fig. 1b, lanes 11-15) , the same defect as that observed when CMG unloading was blocked with p97 inhibitor 1 (p97i; Fig. 1b , lanes 6-10). Wild-type recombinant Xenopus TRAIP (rTRAIP), purified from bacteria or insect cells (Extended Data Fig. 2b, c) , restored the formation of the fast-figure-8 species (Fig. 1b , Extended Data Fig. 2d-h) .
These results suggested that TRAIP promotes CMG ubiquitylation and unloading. Consistent with this idea, we found that TRAIP was required for the dissociation of CDC45 and MCM7 (two subunits of CMG) from pICL Pt (Fig. 1c) , and for efficient loss of the CMG footprint at ICLs (Extended Data Fig. 3a, b ). Loss of the CMG footprint did not require FANCM or ATR signalling (Extended Data Fig. 3c-f ), two factors that mediate fork traverse at ICLs 19, 20 . In addition, MCM7 ubiquitylation was dependent on TRAIP ( Fig. 1c ). This effect was more evident when CMG unloading was blocked with p97i ( Fig. 1d ). Consistent with CMG unloading being required for fork reversal and incisions at an ICL 9 , TRAIP was also required for fork reversal and for errorfree repair of the lesion (Fig. 1e, f) . rTRAIP(R18C)-which harbours a RING-domain mutation (Arg18 to Cys) that is associated with primordial dwarfism 16 -was defective for fast-figure-8 formation, MCM7 ubiquitylation and unloading, fork reversal, and ICL repair ( Fig. 1b-f , Extended Data Fig. 2b-h) . The low activity of rTRAIP(R18C) probably results from a combination of modest defects both in chromatin recruitment ( Fig. 1c, d ) and in E3 ubiquitin ligase activity (see below). Our previous conclusion that BRCA1 is required for CMG unloading 21 resulted from the inadvertent depletion of TRAIP with BRCA1 antiserum (Extended Data Fig. 3i -n). We conclude that TRAIP is required for MCM7 ubiquitylation and CMG unloading in the Fanconi anaemia ICL-repair pathway.
Consistent with CMG unloading at ICLs requiring fork convergence 7 , MCM7 ubiquitylation was also found to depend on convergence ( Fig. 2a ). Thus, either TRAIP is recruited de novo when CMGs converge on an ICL, or it travels with the replisome but only ubiquitylates CMG upon fork convergence. In agreement with the latter Letter reSeArCH scenario, TRAIP associated with the undamaged control plasmid (pCtrl) at levels similar to those seen on pICL (Fig. 2b , compare lanes 2 and 5), and in mammalian cells TRAIP localizes to DNA replication forks in the absence of exogenous insults 16, 18 . Both replication licensing and initiation were essential to recruit TRAIP to chromatin (Extended Data Fig. 4a, b ). TRAIP contains a conserved, C-terminal PIP box (PIP, PCNA-interacting peptide; PCNA, proliferating cell nuclear antigen) 18 , which suggests that PCNA might recruit TRAIP to replication forks. However, a mutated TRAIP that lacks the PIP box (TRAIP(ΔPIP)) still suppresses hypersensitivity to mitomycin C 18 . Accordingly, recombinant Xenopus TRAIP(ΔPIP) suppressed the accumulation of slowfigure-8 species (Extended Data Fig. 2b, g, h) . TRAIP therefore travels with the replisome but ubiquitylates CMG only after fork convergence at an ICL, independently of its PIP box.
CMG unloading during replication termination involves the polyubiquitylation of MCM7 by CRL2 LRR1 (refs 22, 23 ) , and this process does not require TRAIP (Extended Data Fig. 4d, e ). Conversely, MCM7 ubiquitylation at ICLs does not require CRL2 LRR1 (Extended Data Fig. 4f-h) . Unlike replication termination, ICL repair involved TRAIP-dependent ubiquitylation of MCM2, MCM3, MCM4, MCM6, and MCM7, and the partial ubiquitylation of CDC45, but almost no detectable ubiquitylation of PSF1 and PSF3 (Fig. 2c , Extended Data Fig. 5a , b) or other replisome-associated factors (Extended Data Fig. 5c ). Wild-type rTRAIP produced a generally similar ubiquitylation pattern on purified recombinant CMG (Fig. 2d, Extended Data Fig. 5d ), consistent with the direct ubiquitylation of CMG by TRAIP in extracts. rTRAIP(R18C) was partially compromised for in vitro ubiquitylation (Fig. 2d, Extended Data Fig. 5e ). TRAIP-dependent ubiquitin chains on CMG were largely insensitive to treatment with chain-specific deubiquitylating enzymes and the addition of ubiquitin lysine mutants that restrict the formation of specific chain types (Extended Data Fig. 5f-h chains during termination 22 , TRAIP can deposit ubiquitin chains that seem to be heterotypically linked and/or branched.
We recently found that collision of a replication fork with a DNAprotein crosslink leads to TRAIP-dependent ubiquitylation of the crosslink 3 . Here we observed that, upon TRAIP depletion, the leading strand advanced two nucleotides closer to a DNA-protein crosslink, and both wild-type rTRAIP and rTRAIP(R18C) restored the original footprint ( Fig. 2e ). By contrast, no such effect was seen at ICLs (Extended Data Fig. 3a ), which indicates that TRAIP clashes only with bulky obstacles. Thus, TRAIP seems to associate with the leading edge of the replisome, where it non-specifically ubiquitylates lysine residues on proteinaceous obstacles encountered ahead of the fork-including on ubiquitin itself-resulting in complex ubiquitin chains that are not dominated by a single linkage type.
Unlike cisplatin-ICLs, psoralen-ICLs and AP-ICLs (apurinic/ apyrimidinic ICLs, formed between an abasic site in one strand and an adenosine in the other strand) are unhooked by NEIL3 independently of CMG unloading 1 . However, we found that MCM7 was ubiquitylated with similar kinetics at both AP-ICLs and cisplatin-ICLs (Extended Data Fig. 6a ). We therefore asked whether AP-ICL repair requires TRAIP. In mock-depleted extract, slow-figure-8 species that were generated when forks converged on an AP-ICL were converted directly into open circular and supercoiled products by NEIL3-dependent unhooking 1 (Fig. 3a ; for schematic of pICL AP repair intermediates see Extended Data Fig. 1c ). Unlike p97 inhibition-which had no effect on AP-ICL replication 1 (Extended Data Fig. 6b , lanes 26-30)-TRAIP immunodepletion caused a marked accumulation of slow-figure-8 species and a strong reduction in open circular and supercoiled plasmids ( Fig. 3a ). Furthermore, TRAIP depletion greatly reduced AP-ICL repair (Fig. 3b ). The addition of wild-type rTRAIP, purified from bacteria or insect cells, fully reversed these defects ( Fig. 3a, b , Extended Data Fig. 6e , f). rTRAIP(R18C) also mostly reversed these defects, suggesting that lower levels of ubiquitylation are needed to support AP-ICL repair compared with cisplatin-ICL repair ( Fig. 3a , b, Extended Data Fig. 6e ). Thus, TRAIP promotes AP-ICL repair independently of CMG unloading.
We postulated that TRAIP-dependent CMG ubiquitylation recruits NEIL3 to converged forks. Because endogenous NEIL3 on chromatin was undetectable by immunoblotting, we supplemented extract with Flag-tagged recombinant NEIL3 (rNEIL3) and examined its chromatin binding using Flag antibody. rNEIL3 recovery was abolished by Geminin, demonstrating that rNEIL3 binding is replicationdependent (Extended Data Fig. 6a ). We detected more rNEIL3 on pICL Pt than on pICL AP (Extended Data Fig. 6a ), probably because NEIL3 becomes trapped on chromatin when it cannot unhook the ICL (Extended Data Fig. 7a 
ΔTRAIP

R18C
ΔMock rTRAIP  WT  --pDPC 2xlead   10  25  40  60  90  120  10  25  40  60  90  120  10  25  40  60  90 Letter reSeArCH NEIL3-recruitment assays. We also found that the depletion of TRAIP strongly reduced the association of rNEIL3 with pICL Pt (Fig. 3c , lanes 1-8). Recombinant wild-type TRAIP fully rescued and rTRAIP(R18C) partially rescued this defect ( Fig. 3c ). Our data suggest that TRAIPdependent CMG ubiquitylation is required to recruit NEIL3 for the unhooking of ICLs. Consistent with this model, delaying the unloading of CMG extends the window of time during which NEIL3 can unhook an AP-ICL (Extended Data Fig. 7d , e).
NEIL3 contains three zinc-finger motifs C-terminal to its glycosylase domain 24 (Fig. 3d ). NEIL3 lacking the entire C-terminal region (rNEIL3(∆291)) retained glycosylase activity (Extended Data Fig. 8a ) but failed to unhook pICL AP (Fig. 3e ) or bind pICL in extract ( Fig. 3f ), which suggests that one or more of the zinc-fingers helps to recruit NEIL3 to stalled forks. We found that the NPL4-type zinc-finger (NZF) of NEIL3 binds monoubiquitin, and that this interaction is dependent on a conserved NZF TL motif (Extended Data Fig. 8b ), as seen for other NZFs 25 . Notably, pICL AP unhooking was reduced more than twofold by substitution of the TL motif (rNEIL3(T310L/L311V)) and fourfold by substitutions of zinc-coordinating cysteines in the NZF (rNEIL3-NZF(C/A); Fig. 3e ). Consistent with this observation, rNEIL3-NZF(C/A) and rNEIL3(T310L/L311V) showed diminished binding to pICL (Fig. 3f ). The other two NEIL3 zinc-fingers resemble the 'GRF' zinc-finger of APE2 endonuclease, which binds single-stranded (ss)DNA 26 . We found that GRF1 and GRF2 each bound specifically to ssDNA (Extended Data Fig. 8d , e), and point mutations that disrupted this binding compromised the association of NEIL3 with chromatin and its ability to support AP-ICL unhooking (Extended Data Fig. 8f -h). Our data suggest that NEIL3 binds to converged CMGs through cooperation of its NZF (which recognizes ubiquitylated CMG) and its GRFs (which recognize ssDNA, possibly on the lagging strand template) (Extended Data Fig. 8i ).
In Xenopus egg extracts, AP-ICLs and psoralen-ICLs are processed almost exclusively by NEIL3, but in its absence they are unhooked by the Fanconi anaemia pathway 1 . The question arises as to how the NEIL3 pathway is prioritized over the Fanconi anaemia pathway. Notably, rTRAIP(R18C), which forms only short ubiquitin chains on MCM7 ( Fig. 1c, d, 3c ), showed barely detectable activity in cisplatin-ICL repair ( Fig. 1b , f) while promoting robust AP-ICL repair ( Fig. 3a, b ). These observations suggest that short ubiquitin chains might be sufficient to support the NEIL3 pathway but not the Fanconi anaemia pathway. Consistent with this hypothesis, ubiquitin that lacks lysines (Ub(K0))and therefore cannot undergo polyubiquitylation-greatly stabilized pICL Pt slow-figure-8 intermediates (which is indicative of defective p97-dependent CMG unloading), while having only a modest effect on the disappearance of pICL AP slow-figure-8 species, which reflects NEIL3 unhooking ( Fig. 4a ). As expected, Ub(K0) reduced the length of ubiquitin chains formed on MCM7 ( Fig. 4b , red bar). Consistent with its modest effect on the unhooking of AP-ICLs, Ub(K0) did not affect the recruitment of NEIL3 to chromatin (Fig. 4b ). The data suggest that short ubiquitin chains on CMG are sufficient to recruit NEIL3. If the ICL cannot be cleaved by NEIL3-as in the case of cisplatin-ICLs-the chains continue to grow, leading to p97-dependent CMG unloading ( Fig. 4c ). Consistent with the redundancy between the Fanconi anaemia pathway and the NEIL3 pathway for the repair of certain ICLs in mammalian cells, both had to be eliminated in order to observe hypersensitivity to psoralen-ICLs, whereas removal of the Fanconi anaemia pathway alone sensitized HAP1 cells to cisplatin ( Fig. 4d , Extended Data Fig. 9a-d) . A synthetic interaction between the NEIL3 pathway and the Fanconi anaemia pathway was also observed in the CH12 B cell line (Extended Data Fig. 9e-g) . Whether the NEIL3 pathway is prioritized in cells, as seen in extracts, remains to be determined. We have shown that although TRAIP is a constitutive replisome component, it ubiquitylates CMG only upon fork convergence, and this avoids premature CMG unloading from active replisomes (Extended Data Fig. 10a , i). Given our data, the ICL sensitivity of cells that lack TRAIP 18 suggests that a substantial number of ICL repair events in cells require CMG convergence, even though a single fork may often trigger repair 19 . It is notable that TRAIP also supports replication-coupled ubiquitylation of DNA-protein crosslinks 3 (Extended Data Fig. 10a , ii). Moreover, in mitosis, TRAIP ubiquitylates stalled CMGs in the absence of fork convergence, and terminated CMGs that were not unloaded by CRL2 LRR1 (ref. 4 ) (Extended Data Fig. 10a , iii, iv). Collectively our data suggest that, in interphase, TRAIP ubiquitylates only proteins that are located ahead of the replisome. By contrast, in mitosis, TRAIP also ubiquitylates the CMG with which it associates, perhaps owing to a cyclin B1-CDK1-dependent conformational change in TRAIP. We speculate that in humans, the ubiquitylation activity associated with TRAIP(R18C) is sufficient to support the Fanconi anaemia pathway, albeit with slow kinetics; this would suppress the symptoms of Fanconi anaemia while causing a G2 delay, reduced cell proliferation and dwarfism. Consistent with this model, cells from patients with Fanconi anaemia and from patients deficient in TRAIP exhibit slow progression through G2 in the absence of exogenous crosslinking agents 6, 27 , and patients with Fanconi anaemia often exhibit short stature 6 . In conclusion, our results establish TRAIP as a replisomeassociated E3 ubiquitin ligase that controls ICL repair-pathway choice, replisome integrity, and the response to proteinaceous replication barriers.
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The authors declare no competing interests. .0) ). The reactions were treated with 0.16 mg ml −1 RNase A for 1 h at 37 °C, followed by 0.75 mg ml −1 Proteinase K overnight at room temperature. The reactions were then phenol/chloroform extracted, precipitated, and digested with AflIII (for pICL Pt ) for 3 h at 37 °C or Nb.BsmI (for pDPC 2×lead ) for 1 h at 65 °C. After addition of denaturing PAGE Gel Loading Buffer II (Life Technologies), the radiolabelled nascent strands were resolved on a 7% denaturing polyacrylamide gel, transferred to filter paper, dried, and visualized by phosphorimaging on a Typhoon FLA 7000 (GE Healthcare). To enhance the visualization of bands, a logarithmic transform was applied using ImageJ to all nascent strand analyses except those presented in Fig. 2e and Extended Data Figs. 3a, e and 7e. Sequencing gel markers were generating using the Thermo Sequenase Cycle Sequencing Kit (USB Corporation) with primer pICL_Seq that anneals with the pICL plasmids 149 nucleotides upstream of the crosslink. Plasmid pull-down. Plasmid pull-downs were performed essentially as described 38 . In brief, streptavidin-coupled magnetic beads (Invitrogen) were gently rotated with biotinylated LacR 30 for 40 min at room temperature. The beads were washed three times with 20 mM HEPES-KOH (pH 7.7), 100 mM KCl, 5 mM MgCl 2 , 250 mM sucrose, 0.25 mg ml −1 BSA and 0.02% Tween-20, then resuspended in the same buffer. Replication reactions were mixed with the beads at the indicated times and gently rotated for 30 min at 4 °C. The beads were washed three times with 20 mM HEPES-KOH (pH 7.7), 100 mM KCl, 5 mM MgCl 2 , 0.25 mg ml −1 BSA, and 0.03% Tween-20, then resuspended in 2x Laemmli buffer for analysis by immunoblotting. Ubiquitin linkage analysis. A plasmid for expression of the AMSH * deubiquitylating enzyme (pOINB-AMSH * ) 39 
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Immunoblotting. Samples were resolved on Mini-PROTEAN or Criterion TGX precast gels (Bio-Rad) and transferred to PVDF membranes (Perkin Elmer). Membranes were blocked in 5% non-fat milk in 1x PBST for 60 min at room temperature, then incubated with antibody diluted in 1x PBST containing 1% BSA overnight at 4 °C. After extensive washing in 1x PBST at room temperature, the membranes were incubated with goat anti-rabbit horseradish peroxidase-conjugated antibodies (Jackson ImmunoResearch) diluted in 5% non-fat milk in 1x PBST for 1 h at room temperature. Membranes were washed extensively in 1x PBST, briefly incubated with HyGLO chemiluminescent HRP antibody detection reagent (Denville), and imaged using an Amersham Imager 600 (GE Healthcare). Contrast was occasionally adjusted to improve visualization of bands. Error-free repair assay. The error-free repair assay was performed as previously described 40 . In brief, replication reactions were stopped at the indicated time points with 10 volumes of Stop Solution B. The reactions were treated with 0.16 mg ml −1 RNase A for 1 h at 37 °C, followed by 0.75 mg ml −1 Proteinase K overnight at room temperature. The reactions were then phenol/chloroform extracted, precipitated and digested with HincII or HincII and SapI for 3 h at 37 °C. After the addition of 0.17 volumes of DNA loading buffer (10 mM Tris-HCl (pH 7.5), 60% glycerol and 0.5% bromophenol blue), the digestion products were resolved by 0.8% native agarose gel electrophoresis, dried, and visualized by phosphorimaging on a Typhoon FLA 7000 (GE Healthcare). Repair products were quantified using ImageJ (NIH). Purification of recombinant Xenopus NEIL3. X. laevis NEIL3 was purified as previously described 1 . In brief, constructs for the expression of rNEIL3-NZF(C/A), rNEIL3(T310L/L311V), rNEIL3(K500E), rNEIL3(K546E), rNEIL3(K500E/K546E) and rNEIL3(∆92) were prepared by digesting Integrated DNA Technologies gene blocks encompassing the C-terminal domain of NEIL3 (with Flag epitope tag) and containing the indicated mutations with BbvCI and XhoI and then ligating the fragments into similarly digested pFastBac1-NEIL3-Flag 1 . The rNEIL3(∆291) expression construct was prepared by PCR amplification of the NEIL3 glycosylase domain from a X. laevis cDNA library (a gift from T. G. W. Graham) using primers NEIL3_291_A and NEIL3_291_B. The fragment was then digested with EcoRI and XhoI and ligated into similarly digested pFastBac1 (Thermo Fisher Scientific). All mutations and truncations were confirmed by Sanger sequencing. Baculoviruses expressing rNEIL3 were then prepared using the Bac-to-Bac system (Thermo Fisher Scientific) according to the manufacturer's protocols. rNEIL3 protein was expressed in 250 ml suspension cultures of Sf9 insect cells (Expression Systems) by infection with baculovirus expressing NEIL3-Flag for 48-72 h. Sf9 cells were collected and suspended in 10 ml NEIL3 Lysis Buffer (50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 10% glycerol, 1x Roche EDTA-free cOmplete protease inhibitor cocktail, 0.5 mM PMSF and 0.2% Triton X-100). Cells were lysed by sonication, and the soluble fraction was collected by spinning the lysate at 25,000 r.p.m. in a Beckman SW41 rotor for 1 h. The soluble lysate was incubated with 200 µl anti-Flag M2 affinity resin (Sigma-Aldrich) for 90 min at 4 °C. The resin was washed once with 10 ml Lysis Buffer, twice with NEIL3 Wash Buffer (50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 10% glycerol and 0.2% Triton X-100), and three times with Buffer A (50 mM Tris-HCl (pH 7.5), 300 mM NaCl and 10% glycerol). NEIL3-Flag protein was eluted from the resin with Buffer A containing 100 µg ml −1 3×Flag peptide (Sigma-Aldrich). Elution fractions containing NEIL3-Flag protein were pooled and dialysed against 50 mM HEPES-KOH (pH 7.0), 300 mM NaCl, 1 mM DTT and 20% glycerol at 4 °C for 12 h and then dialysed against 50 mM HEPES-KOH (pH 7.0), 150 mM NaCl, 1 mM DTT and 15% glycerol at 4 °C for 3 h. Aliquots of protein were stored at −80 °C. Constructs for expression of GST-TEV-NZF (GST, glutathione S-transferase; TEV, tobacco etch virus) fusion proteins were prepared by PCR amplification of the NEIL3 NZF from pFastBac1-NEIL3-Flag and pFastBac1-NEIL3(T310L/L311V)-Flag using primers NEIL3_NZF_A and NEIL3_NZF_B. The pGEX-6P-1 backbone (with GST-TEV tag) was PCRamplified from pGEX-6P-1-GST-TEV-Flag-UBXN7 with primers GST_A and GST_B. The resulting fragments were then assembled using the NEBuilder HiFi DNA assembly cloning kit (New England Biolabs) according to the manufacturer's instructions. Expression of GST-TEV-NZF proteins was induced in 1 l Rosetta 2 (DE3) pLysS cells (Novagen) with 0.5 mM IPTG for 3 h at 37 °C. Bacterial cell pellets were suspended in Buffer A (10 mM sodium phosphate (pH 7.4), 150 mM NaCl, 5 mM β-mercaptoethanol, 10 µM ZnCl 2 and 1x Roche cOmplete protease inhibitor cocktail) and sonicated. The soluble lysate was collected after centrifugation at 25,000 r.p.m. in a SW40.1 rotor for 1 h and bound to Glutathione Sepharose 4B (GE Healthcare) for 1.5 h at 4 °C. The bound resin was then washed five times with Buffer A and protein was eluted with Buffer B (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 10 µM ZnCl 2 , 5 mM β-mercaptoethanol and 20 mM glutathione). Fractions containing GST-TEV-NZF fusion proteins were dialysed against 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 10 µM ZnCl 2 , 5 mM β-mercaptoethanol and 10% glycerol at 4 °C and aliquots were stored at −80 °C. Constructs for expression of MBP-TEV-GRF ZF fusion proteins were prepared by amplifying the NEIL3 GRF ZF1 or GRF ZF2 from pFastBac1-NEIL3-Flag or pFastBac1-NEIL3(K500E/ K546E)-Flag using primers GRFZF1_A and GRFZF1_B or GRFZF2_A and GRFZF2_B, respectively. The MBP tag was PCR-amplified using the primers MBP_A and MBP_B or MBP_A and MBP_C for GRF ZF1 and GRF ZF2 respectively. The pGEX-6P-1 backbone was PCR-amplified from pGEX-6P-1-GST-TEV-Flag-UBXN7 with primers pGEX_A and pGEX_B. The resulting fragments were then assembled using the NEBuilder HiFi DNA assembly cloning kit (New England Biolabs) according to the manufacturer's instructions. Expression of MBP-TEV-GRF ZF proteins was induced in 1 l Rosetta 2 (DE3) pLysS cells (Novagen) with 0.5 mM IPTG for 3 h at 37 °C. Bacterial cell pellets were suspended in Buffer C (20 mM Tris-HCl (pH 7.5), 300 mM NaCl, 1 mM DTT and 1x Roche cOmplete protease inhibitor cocktail) and sonicated. The soluble lysate was collected after centrifugation at 25,000 r.p.m. in a SW40.1 rotor for 1 h and bound to amylose resin (New England Biolabs) for 1.5 h at 4 °C. The bound resin was then washed six times with Buffer C and protein was eluted with Buffer C containing 10 mM maltose. Fractions containing MBP-TEV-GRF ZF fusion proteins were dialysed against 20 mM Tris-HCl (pH 8.0), 200 mM NaCl, 1 mM DTT and 10% glycerol at 4 °C and aliquots were stored at −80 °C. Purification of recombinant Xenopus TRAIP. The X. laevis TRAIP open reading frame was PCR-amplified from a X. laevis cDNA library (a gift from T. G. W. Graham) using primers TRAIP_A and TRAIP_B or TRAIP_C and TRAIP_D. For expression in bacteria, the product amplified with TRAIP_A and TRAIP_B was gel-isolated, digested with BamHI and ligated into pH 6 -SUMO 41 linearized with BamHI. For expression in Sf9 insect cells, the product amplified with TRAIP_C and TRAIP_D was gel-isolated, digested with BssHII and NotI, and ligated in pFastBac1 (Life Technologies) digested with BssHII and NotI. A 3×Flag tag and 3C protease cleavage site were introduced by linearizing the resulting plasmid with BssHII and ligating a linker comprising annealed oligonucleotides 3×F_3C_Top_1, _2, _3 and 3×F_3C_Bottom_1, _2, _3, and _4. The R18C substitution was introduced by 'around-the-horn' PCR 42 using primers R18C_A and R18C_B. pH 6 -SU-MO-TRAIP(ΔPIP) (residues 1-455) was constructed by around-the-horn PCR using primers PIP_A and PIP_B. All mutations and truncations were confirmed by Sanger sequencing.
His 6 -SUMO-TRAIP was expressed in Rosetta 2 (DE3) pLysS (Novagen) by induction with 0.1 mM IPTG overnight at 16 °C in growth media supplemented with 50 µM ZnSO 4 . Bacterial pellets were resuspended in TRAIP Lysis Buffer (20 mM HEPES-NaOH (pH 7.5), 400 mM sodium acetate, 10% glycerol, 10 µM ZnSO 4 , 0.1% NP-40, 1 mM DTT and 1x Roche cOmplete protease inhibitor cocktail) supplemented with 20 mM imidazole. After sonication, ammonium sulfate and polyethyleneimine were added to the lysate to final concentrations of 300 mM and 0.45%, respectively and incubated for 15 min at 4 °C. The soluble fraction was collected after centrifugation at 40,000g for 45 min at 4 °C, and precipitated with saturating ammonium sulfate. The precipitated fraction was collected after centrifugation at 40,000g for 45 min at 4 °C, resuspended in Lysis Buffer, and then rotated with NiNTA resin (Qiagen) for 30 min at room temperature. The resin was washed three times with Wash Buffer (20 mM HEPES-NaOH (pH 7.5), 400 mM sodium acetate, 10% glycerol, 20 mM imidazole, 10 µM ZnSO 4 , 0.01% NP-40, 1 mM DTT and 1x Roche cOmplete protease inhibitor cocktail). His 6 -SUMO-TRAIP was eluted from the resin with Elution Buffer (20 mM HEPES-NaOH (pH 7.5), 400 mM sodium acetate, 10% glycerol, 250 mM imidazole, 0.01% NP-40 and 1 mM DTT). Elution fractions containing His 6 -SUMO-TRAIP were pooled and dialysed against Dialysis Buffer (20 mM HEPES-NaOH (pH 7.5), 400 mM sodium acetate, 10% glycerol, 0.01% NP-40 and 1 mM DTT) supplemented with 120 mM imidazole overnight at 4 °C. With the exception of the indicated proteins used in Extended Data Figs. 2b, g, h, and 6e , the His 6 -SUMO was simultaneously cleaved by the addition of 0.03 mg ml −1 Ulp1 during dialysis. Aliquots were flash frozen and stored at −80 °C.
Baculoviruses expressing 3×Flag-3C-rTRAIP (wild-type) or 3×Flag-3C-rTRAIP(R18C) were prepared using the Bac-to-Bac system (Thermo Fisher Scientific) according to the manufacturer's protocols. rTRAIP protein was expressed in 200 ml suspension cultures of Sf9 insect cells (Life Technologies) by infection with baculovirus for 72 h. Sf9 cells were collected and suspended in 10 ml TRAIP Lysis Buffer. After sonication, the soluble lysate was collected after centrifugation at 30,000 r.p.m. in a 45Ti rotor for 1 h and bound to anti-Flag M2 affinity agarose gel (Sigma-Aldrich) for 2 h at 4 °C. The bound resin was then washed five times with TRAIP Lysis Buffer and eluted with TRAIP Lysis Buffer supplemented with 100 µg ml −1 3× Flag peptide (Sigma-Aldrich). Elution fractions containing 3×F-3C-rTRAIP were pooled incubated overnight at 4 °C in the presence of 3C protease. Aliquots were flash-frozen and stored at −80 °C. Purification of recombinant Xenopus CMG. The open reading frames encoding the eleven X. laevis CMG subunits (CDC45, MCM2-7 hetero-hexamer, and GINS hetero-tetramer) were cloned into a single plasmid (pGC187) using the MultiBac system 43 CMG baculovirus was generated by transfecting pGC187 bacmid into Sf9 cells (Expression Systems) for 96 h, and amplifying the virus in two rounds of 96 h each. Individual subunit expression levels were monitored by immunoblotting. 500 ml of Tni (similar to HiFive) cell culture (Expression Systems) at a density of 2-3 million cells per ml was infected with 50 ml baculovirus (multiplicity of infection > 10). Cells collected 72 h post-infection were pelleted at 500g for 15 min, frozen in liquid nitrogen and stored at −80 °C.
The frozen pellet was re-suspended to a final volume of 50 ml in CMG Lysis Buffer (CLB; 20 mM Tris-HCl (pH 7.5), 10% glycerol, 5 mM magnesium acetate, 300 mM potassium acetate, 0.1% Tween20, 1 mM PMSF, 0.2 mM ATP and 1x Roche EDTA-free cOmplete protease inhibitor cocktail). Cells were lysed by sonication on ice or by Dounce homogenization and the insoluble fraction was pelleted via centrifugation for 1 h at 30,000g at 4 °C. The clarified lysate was incubated with 1 ml M2 anti-Flag resin (Sigma-Aldrich) for 1 h at 4 °C on a rotating wheel. The resin was washed five times with 10 ml of CLB in a disposable column. The protein was eluted twice with 1 ml each of CLB supplemented with 0.2 mg ml −1 3×Flag peptide (Sigma-Aldrich) for 1 h at 4 °C. Eluted fractions were frozen in liquid nitrogen and stored at −80 °C until the ion-exchange polishing could be performed.
The ion exchange polishing procedure was adapted from a previous study 44 . Ion exchange was performed on a GE AKTA FPLC using CMG Start Buffer (25 mM HEPES (pH 7.6), 10% glycerol, 0.02% Tween20, 1 mM EDTA, 1 mM EGTA, 0 mM KCl, 0.4 mM PMSF, 1 mM DTT) and CMG Elution Buffer (25 mM HEPES (pH 7.6), 10% glycerol, 0.02% Tween20, 1 mM EDTA, 1 mM EGTA, 1,000 mM KCl, 0.4 mM PMSF and 1 mM DTT). The Flag eluate was diluted threefold with CMG Start Buffer to a final salt concentration of 100 mM and loaded onto two columns connected in tandem: MonoS 5/50 GL (GE Healthcare) and MonoQ 5/50 GL (GE Healthcare) such that the flowthrough from MonoS passed through MonoQ. In this scheme, MonoS trapped some contaminants whereas MonoQ bound CMG and its subcomplexes. After loading the protein, the columns were washed with 10 ml of 10% CMG Elution Buffer, then MonoS was disconnected. MonoQ was eluted with 30 ml 10-60% CMG Elution Buffer gradient and 0.5 ml fractions were collected. Stoichiometric CMG complex eluted at 450-500 mM KCl. CMG stoichiometry and purity were verified by SDS-PAGE imaged with SYPRO Ruby. A preparation from 0.5 l of Tni cell culture usually yielded 0.1 mg of very pure CMG (Extended Data Fig. 5d ).
Purified CMG was further concentrated by ion exchange on a MonoQ PC 1.6/5 (GE Healthcare) using an AKTA FPLC as previously described 44 , or by ion exchange on small volumes of NuviaQ resin (Bio-Rad). To perform the latter, MonoQ fractions containing CMG were diluted threefold with CMG Start Buffer for a final KCl concentration of 150 mM and incubated for 1 h at 4 °C with 40 µl of NuviaQ resin pre-equilibrated in 15% CMG Elution Buffer. The resin was washed three times with 400 µl 15% CMG Elution Buffer in a small disposable column (Pierce), then three times with 400 µl 30% CMG Elution Buffer. Each time the flowthrough was collected via centrifugation for 30 s at 500g in a refrigerated tabletop centrifuge with a swing-bucket rotor. CMG was eluted by incubating the washed resin with 40 µl 60% CMG Elution Buffer for 15 min and collected via centrifugation. Any protein that remained bound to the resin was eluted with 40 µl 100% CMG Elution Buffer. Aliquots (3-5 µl) of concentrated CMG (0.5-1.0 µM) were frozen in liquid nitrogen and stored at −80 °C. In vitro CMG ubiquitylation assay. A ubiquitylation assay using an equimolar mixture of the E2 ubiquitin conjugating enzymes UbcH5a, UbcH5b, and UbcH5c, wild-type rTRAIP or rTRAIP(R18C) at an approximate final concentration of 15 nM, and, where included, recombinant CMG at an approximate final concentration of 150 nM was performed using the Enzo BML-UW9920 Ubiquitinylation Kit according to the manufacturer's instructions (Enzo Life Sciences). Reaction products were then resuspended in 1x Laemmli buffer and analysed by immunoblotting. For reactions containing rCMG, products were bound to anti-Flag M2 affinity agarose gel (Sigma-Aldrich) for 30 min at room temperature. Bound beads were washed 3 times with egg lysis buffer (10 mM HEPES (pH 7.7), 50 mM KCl, 2.5 mM MgCl 2 , 2.5 M sucrose), and treated with USP2 for 30 min at 37 °C as indicated before immunoblotting. Electron microscopy. Electron microscopy analysis of the replication intermediates was performed as previously described 9 . In brief, replication reactions were stopped at 90 min with 10 volumes of Stop Solution C (100 mM Tris-HCl (pH 7.5), 6.7 mM MgCl 2 , 1 mM EDTA (pH 8.0) and 1% SDS). The DNA was crosslinked with trimethylpsoralen (Sigma-Aldrich) and irradiation with UV light at 365 nM before protein extraction and DNA purification. Purified DNA was incubated with Escherichia coli single-stranded DNA binding protein, fixed with 0.3% glutaraldehyde, then purified by size-exclusion chromatography. Eluted complexes were mounted onto grids, which were then subjected to rotary shadowing with platinum and carbon coating using a Leica Ace600 coating system. Samples were imaged using a JEOL 1200EX transmission electron microscope equipped with a 2k charge-coupled device camera (Advanced Microscopy Techniques). After blinding the scorer to the conditions, reversed forks were counted and expressed as a percentage of pre-incision structures, which was then normalized to the mock-depleted condition. Electrophoretic mobility shift assay. MBP-TEV-GRF ZF fusion protein was incubated with 10 nM 5′-end-radiolabelled 25mer ssDNA (EMSA_Top) or double-stranded (ds)DNA (EMSA_Top + EMSA_Bottom) in buffer containing 1 mM MgCl 2 , 100 µM ZnSO 4 , 10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.2 mM TCEP and 5% glycerol for 30 to 60 min at 4 °C. Binding reactions were separated on native 5% acrylamide (37.5:1), 45 mM Tris, 45 mM borate, 1 mM MgCl 2 , 100 µM ZnSO 4 gels and visualized by phosphorimaging on a Typhoon FLA 7000 (GE Healthcare). NEIL3 glycosylase assay. AP-ICLs between complementary DNA and DNA/RNA chimaeric oligonucleotides AP_assay_A and AP_assay_B were crosslinked, RNase H digested, and gel purified as described 1 where R max is the globally constrained maximum association response. Cell lines. Wild-type and NEIL3-knockout HAP1 near-haploid human cells were purchased as authenticated from Horizon Discovery and cultured at 37 °C and 5% CO 2 in IMDM (Gibco) supplemented with 10% fetal calf serum (Gibco) and penicillin/streptomycin (Gibco). NEIL3-knockout cells were confirmed by immunoblotting against NEIL3. For targeting of FANCL, wild-type and NEIL3-knockout cells were transfected with Turbofectin 8.0 (Origene) and the following plasmids: pX461, FANCL_left and FANCL_right CRISPR guides in U6 BsaI backbone, and FANCL-Puro targeting construct (Extended Data Fig. 9b ). FANCL plasmids were obtained from the Wellcome Trust Sanger Institute. Two days post-transfection, 3.5 µg ml −1 puromycin (Gibco) was added, and two days later, cells were plated in 96-well plates with puromycin. After 14 days of incubation, individual clones were picked and analysed for FANCL targeting using the SequalPrep Long PCR kit (Applied Biosystems) (see Supplementary Table 1 for primer sequences). Targeted clones were then plated with 100 ng ml −1 mitomycin C (Sigma-Aldrich) overnight and analysed by immunoblotting for FANCD2. FANCL knockouts were identified by failure to ubiquitylate FANCD2 upon exposure to mitomycin C.
CH12-F3 murine B lymphoma cells (a generous gift from M. Neuberger, MRC Laboratory of Molecular Biology) were cultured at 37 °C and 5% CO 2 in RPMI (Gibco) supplemented with 10% fetal calf serum, penicillin/streptomycin, and 10 µM β-mercaptoethanol. To target Neil3 and Fancb, CH12 cells were transfected using the Lonza Nucleofection Kit V and the following plasmids: pX458 and CRISPR guides against either Neil3 exon 1 or 2 (Neil3_exon1 and Neil3_exon2) and/or a Fancb guide against exon 5 (Fancb_319). Two days after transfection, GFP-positive cells were singly sorted by flow cytometry into 96-well plates, and cultured for 7-10 days to obtain single colonies that were screened by PCR fragment analysis. The target exons of Neil3 in putative clones were then amplified and cloned into the pMiniT 2.0 vector (NEB) and sequenced. Neil3 clone 1 carried deletion in each allele of exon 2 of sizes 14-and 26-bp respectively, while clone 2 carried a 38-and 6-bp deletion in each allele of exon 1. Fancb clone 1 carried a 359-bp deletion in exon 5 and clone 2 carried a 21-bp deletion. Neil3 clones were subsequently targeted for Fancb to generate double knockouts; clone 1 had a 4-bp deletion in Fancb exon 5, clone 2 had a 10-bp deletion, and clone 3 had a Letter reSeArCH 24-bp deletion. Disruption of Fancb function was tested by treating all clones with mitomycin C before detection for the loss of FANCD2 monoubiquitylation by immunoblotting as described above.
All cell lines were tested to be mycoplasma negative using the MycoAlert Mycoplasma Detection Kit (Lonza). Colony survival assay. For the cisplatin colony survival assay, HAP1 cells were prepared at 2 × 10 5 cells per ml. Cells and cisplatin (diluted in culture media) were mixed in 96-well blocks (Greiner Bio-One Masterblock) and foil seals (Bio-Rad Microseal 'F') were applied before culturing cells at 37 °C for 2 h. Cells were then serially diluted in PBS using a multi-channel pipette to obtain 1:10 and 1:100 dilutions, and 100 µl of each of three concentrations were plated in duplicate in 24-well plates filled with 1.5 ml of culture media per well. Cells were cultured for 6 days before being stained with crystal violet 46 and colonies were quantified by a GelCount colony counter (Oxford Optronix).
For the trioxsalen colony survival assay, cells were seeded in 24-well plates at 1.2 × 10 5 cells per well for 5 h before the addition of trioxsalen (Sigma-Aldrich) and then cultured for 1 h. Cells were then exposed to 6 kJ m −2 of UVA light (365 nm, VL-6.L lamp) through the bottom of the tissue culture plate to photoactivate trioxsalen. The cells were washed twice with culture media, incubated at 37 °C for 10 min to offload unbound trioxsalen, then washed again and treated with 12 kJ min −1 m −2 UVA to convert trioxsalen monoadducts into ICLs 47, 48 . Cells were then trypsinized, diluted, plated, cultured, and stained as above.
Cell viability assay. CH12 cells were plated in flat-bottom 96-well plates at 5,000 cells per well and cultured with trioxsalen for 1 h, then exposed to 12 kJ min −1 m −2 UVA. Cells were then cultured for 3 days before being assayed with the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega). Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Fig. 1 | DNA replication and ICL repair in Xenopus egg extracts. a, Schematic of pICL replication in the nucleus-free Xenopus egg extract system 49 . Incubation of the plasmid in high-speed supernatant supports the recruitment of inactive MCM2-MCM7 double hexamers (red hexamers; 'Licensing'). Addition of NPE activates replication initiation, including the assembly of active CMG helicases (green hexamers), and elongation of nascent strands (red lines) leads to convergence of forks at the ICL. b, Intermediates generated during replication-coupled repair of a cisplatin-ICL. Top, progression through the incision-dependent Fanconi anaemia repair pathway generates distinct intermediates resulting from fork convergence, CMG unloading, leading strand approach to the ICL, fork reversal, incisions, and repair of the double strand break by homologous recombination. Bottom, deproteinization of the DNA intermediates depicted along the top yields DNA structures that travel with characteristic mobilities during native agarose gel electrophoresis. These structures are indicated along the side of the gel and with coloured dots and/or arrows in Fig. 1b and other figures. The slow-figure-8 species arise upon fork convergence on the ICL (Fig. 1b, purple dot) . Conversion of slow-to fast-figure-8 species results from CMG unloading and an accompanying change in plasmid topology 9 (Fig. 1b, orange dot) . Next, a species of intermediate mobility appears (Fig. 1b, green arrow) , which represents reversed forks, as shown by electron microscopy 9 . After XPF-dependent unhooking of the reversed structure 9,50 , double-strand DNA break repair generates joining products that barely enter the gel 51 (Fig. 1b, well product) . Some of these species are resolved into monomeric, supercoiled plasmids that represent the final, fully repaired product (Fig. 1b, SC) that is sensitive to SapI digestion. c, Intermediates generated during replication-coupled repair of an AP-ICL (pICL AP ). Top, progression through the NEIL3 repair pathway generates intermediates resulting from fork convergence, NEIL3-dependent N-glycosyl bond cleavage, nascent strand ligation, decatenation, and TLS. Bottom, deproteinization of the DNA intermediates depicted along the top yields DNA structures that travel with characteristic mobilities during native gel electrophoresis. These structures are indicated along the side of the gel and with coloured dots in Fig. 3a and other figures. Fig. 3 | TRAIP, but not FANCM, ATR or BRCA1 , is required for CMG unloading at cisplatin-ICLs. a, Left, schematic of nascent strands generated at ICLs. When forks converge on an ICL, nascent strands stall about 20 nucleotides from the ICL on either side of the lesion owing to the footprint of CMG (green hexamer). AflIII cuts 144 nucleotides to the left and 534 nucleotides to the right of the ICL, generating characteristic products for the leftward and rightward leading strands upon fork convergence, CMG unloading, and leading strand extension. Right, nascent strand analysis of pICL Pt replication in the indicated extracts. After replication with [α-32 P]dATP, nascent strands were extracted, digested with AflIII and resolved on a denaturing polyacrylamide gel alongside a sequencing ladder and visualized by autoradiography. As seen previously 2, 52 , when replication forks converged on the ICL in mock-depleted egg extracts, leading strands initially stalled 20-40 nucleotides from the lesion (lane 1) and then advanced to the −1 position (lanes 2-6), which depends on CMG dissociation 21, 52 . By contrast, in TRAIP-depleted egg extracts, the −20 footprint persisted for three hours (lanes 7-12) . This effect was rescued with wild-type rTRAIP but not rTRAIP(R18C) (lanes [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Two independent experiments. b, Extracts used in the replication reaction shown in a were analysed for TRAIP. Two independent experiments. c, Mock-depleted or FANCM-depleted extracts were analysed for FANCM. A non-specifically detected protein is marked with an asterisk. Two independent experiments. d, Nascent strand analysis of pICL Pt replicating in mock-depleted or FANCM-depleted extracts was performed as in a. The CMG footprint disappeared at the ICL in FANCM-depleted egg extract, consistent with FANCM not being required for CMG unloading at ICLs. Two independent experiments. e, pICL Pt was replicated in the absence or presence of ATR inhibitor ETP-46464 (ATRi), and nascent strand analysis was performed as in a. ATR inhibitor was added to the reaction 2.5 min after initiation. The CMG footprint disappeared at the ICL with or without ATR inhibitor, indicating that ATR signalling is not required for CMG unloading at ICLs. Two independent experiments. f, Extracts used in e were sampled at various time points and analysed for Xenopus CHK1 serine-344 phosphorylation to verify ATR inhibition. MCM6 was detected as a loading control. Two independent experiments. g, h, Mock-depleted and TRAIP-depleted extracts used in one of the replicate reactions quantified in Fig. 1e (g) and Fig. 1f (h) were analysed for TRAIP. Two independent experiments were performed for g and three independent experiments were performed for h. i, We previously showed that the immunodepletion of BRCA1 from egg extracts inhibits CMG unloading at ICLs, but this defect could not be rescued with recombinant BRCA1-BARD1 complex 8, 21 . To test whether TRAIP is codepleted with BRCA1, NPE was immunodepleted of BRCA1 with BRCA1 antiserum, loaded alongside a dilution series of mock-depleted NPE, and analysed for BRCA1 and TRAIP. A relative loading amount of 100 corresponds to 2 µl of NPE. Non-specifically detected proteins are marked with asterisks. This analysis revealed that immunodepletion of BRCA1 also removed TRAIP from NPE. We also observed TRAIP co-depletion with antibodies against other proteins (data not shown), suggesting that it interacts non-specifically with different antibodies. Two independent experiments. j, The extracts described in i were supplemented with pICL Pt , [α-32 P]dATP and rTRAIP, as indicated, and analysed as in Fig. 1b . Wild-type rTRAIP suppressed the stabilization of the slow-figure-8 species seen in BRCA1-depleted extract, consistent with the restoration of CMG unloading, and indicating that the unloading defect seen in BRCA1-depleted egg extracts is due primarily to the removal of TRAIP from the extract. Two independent experiments. k, The extracts used in j were analysed for TRAIP. Two independent experiments. l, To determine whether BRCA1 contributes to TRAIP-dependent CMG unloading, NPE was immunodepleted of TRAIP or TRAIP and BRCA1 using Protein A Sepharose-purified antibodies purified from antiserum. A dilution series of mock-depleted NPE was loaded alongside the depleted extracts, and extracts were analysed for BRCA1 and TRAIP. A relative loading amount of 100 corresponds to 2 µl of NPE. Two independent experiments. m, The extracts described in l were supplemented with pICL Pt , [α-32 P] dATP and rTRAIP, as indicated, and analysed as in Fig. 1b . Wild-type rTRAIP suppressed the accumulation of slow-figure-8 species to a similar extent in TRAIP-depleted egg extracts whether or not BRCA1 was codepleted (lanes [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , indicating that BRCA1 is not needed to support TRAIP function. BRCA1 depletion reproducibly resulted in a decrease in well-product formation, suggesting a role for BRCA1 in recombination after a double-strand break is formed by ICL-unhooking incisions. Two independent experiments. n, The extracts used in m were analysed for TRAIP. Two independent experiments. Fig. 9 | Knockout of the Fanconi anaemia and NEIL3 pathways have additive effects on ICL sensitivity in mammalian cells. a, Immunoblot analysis of NEIL3 expression in wild-type, NEIL3knockout and FANCL/NEIL3-knockout HAP1 cell lines. Histone H3 was detected as a loading control. Non-specifically detected proteins are marked with asterisks. Analysis performed twice. b, Schematic of FANCL targeting by CRISPR. (i) Human FANCL exon 10, single-guide (sg)RNA binding sites, and homology arm targets; (ii) FANCL-Puro targeting construct with homology arms flanking exon 10; (iii) Targeted FANCL allele with integrated puromycin-resistance cassette. c, Detection of the integrated puromycin-resistance cassette in HAP1 cells by FANCL long-range PCR. Analysis performed twice. d, Analysis of FANCD2 ubiquitylation in mitomycin-C-treated wild-type, FANCL-knockout and FANCL/NEIL3-knockout HAP1 cell lines to confirm FANCL knockout. Vinculin was detected as a loading control. FANCL is the catalytic subunit of the Fanconi anaemia core complex, which ubiquitylates FANCD2. Analysis performed twice. e, Neil3 qRT-PCR confirming gene disruption in CH12 cell lines. ND, not detected. Analysis performed once. f, Analysis of FANCD2 ubiquitylation in mitomycin-C-treated Fancb-knockout and Neil3/Fancb-knockout CH12 cell lines to confirm Fancb knockout. Vinculin was detected as a loading control. A non-specifically detected protein is marked with an asterisk. Analysis performed once. g, Cell viability of wild-type, Fancb-knockout, Neil3-knockout or Fancb/Neil3knockout CH12 cells after exposure to trioxsalen and UVA irradiation. Two independent clones were used for the single mutants and three independent clones were used for the double mutant. Data are mean ± s.e.m. We speculate that, relative to HAP1 cells, CH12 cells may be more reliant on the Fanconi anaemia pathway to repair trioxsalen-induced damage owing to lower expression levels of NEIL3. Three independent experiments.
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